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Background
CB1 and CB2 cannabinoid receptors are G protein-coupled
receptors which have been described to couple mainly to
the Gi/o subfamily of G proteins. However, in some cell
types and upon stimulation with certain cannabinoid
agonists, activation of other G protein subtypes has also
been observed. GPR55 is an orphan G protein-coupled
receptor which has been suggested to be a novel member
of the cannabinoid receptor family.
Methods
In this study we wanted to characterize the G protein acti-
vation properties of the two known cannabinoid recep-
tors and GPR55 following stimulation with different
cannabinoid ligands, using bioluminescence resonance
energy transfer (BRET). We monitored the activation of
different G protein subtypes (Go, Gq, Gs or G12) using
Renilla luciferase-tagged wild type or chimeric Gαo subu-
nits (i.e. Gαo with the C-terminal 5 amino acids replaced
with those of Gαq, Gαs or Gα12, respectively) co-expressed
with EYFP-tagged α1α11 subunit and the receptor in CHO
cells.
Results
We found that CB1 was able to activate all four subtypes of
G proteins, with different pharmacokinetic properties, fol-
lowing stimulation by non-selective (WIN55 and 2-AG)
or CB1-selective (ACEA) cannabinoid agonists. Basal
activity of CB1 could also be detected with Go and G12 sub-
types, as the CB1 inverse agonist AM251 caused significant
BRET increase (i.e. G protein subunit association) when
tested with these G proteins. In contrast, CB2 showed no
G protein activation other than Go, upon either WIN55 or
2-AG stimuli. Stimulation of GPR55 with WIN55, 2-AG or
AM251 did not alter the activity of the tested G proteins
even at considerably high ligand concentrations.
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